Analysis of the promoter of the NAD + dependent 11β-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells

Molecular and Cellular Endocrinology

Volumn 121, Issue 1, 1996, Pages 93-99

  Agarwal, Anil K ^a   White, Perrin C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hydroxysteroid dehydrogenases; Luciferase; Placenta; Transcriptional regulation

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DNA; LUCIFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CHORIOCARCINOMA; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; DNA FOOTPRINTING; DNA PROTEIN COMPLEX; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; ENZYME REGULATION; GENE STRUCTURE; HUMAN; HUMAN CELL; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0030598651     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(96)03855-5     Document Type: Article

References (21)

1. [1] Agarwal, A.K., Mune, T., Monder, C. and White, P.C. (1994) NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269, 25959-25962.
2. [2] Agarwal, A.K., Rogerson, F.M., Mune, T. and White, P.C. (1995) Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 β-hydroxysteroid dehydrogenase. Genomics 29, 195-199.
3. [3] Agarwal, A.K., Tusie-Luna, M.T., Monder, C. and White, P.C. (1990) Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 4, 1827-1832.
4. [4] Albiston, A.L., Obeyesekere, V.R., Smith, R.E. and Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11-HSD type 2 enzyme. Mol. Cell Endocrinol. 105, R11-R17.
5. [5] Benediktsson, R., Lindsay, R.S., Noble, J., Seckl, J.R. and Edwards, C.R. (1993) Glucocorticoid exposure in utero: new model for adult hypertension [published erratum appears in Lancet 1993 Feb 27; 341(8844):572] [see comments]. Lancet 341, 339-341.
6. [6] Biggin, M.D. and Tjian, R. (1989) Transcription factors and control of Drosphila development. Trends Genet. 5, 377-383.
7. [7] Briggs, M.R., Kadonaga, J.T., Bell, S.P. and Tjian, R. (1986) Purification and biochemical characterization of the promoter-specific transcription factor, Spl. Science 234, 47-52.
8. [8] Dignam, J.D., Martin, P.L., Shastry, B.S. and Roeder, R.G. (1991) Eukaryotic gene transcription with purified components. Methods Enzymol. 101, 582-598.
9. [9] Fawcett, T.W. and Bartlett, S.G. (1990) An effective method for eliminating 'artifact banding' when sequencing double-stranded DNA templates. Biotechniques 9, 46-49.
10. [10] Harrington, M.A., Konicek, B., Song, A., Xia, X., Fredericks, W.J. and Rauscher, F.J. (1993) Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268, 21271-21275.
11. [11] Joseph, L.J., LaBeau, M.M., Jamieson, G.A., Acharya, S., Shows, T.B., Rowley, J.D. and Sukhatme, V.P. (1988) Molecular cloning, sequencing and mapping of EGR2, a human early growth response gene encoding a protein with 'zinc-binding finger' structure. Proc. Natl. Acad. Sci. USA 85, 7164-7168.
12. [12] Lakshmi, V. and Monder, C. (1988) Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex. Endocrinology 123, 2390-2398.
13. [13] Mackman, N., Morrissey, J.H., Fowler, B. and Edgington, T.S. (1989) Complete sequence of the human tissue factor gene, a highly cellular receptor that initiates the coagulation protease cascade. Biochemistry 28, 1755-1762.
14. [14] Martin, M.E., Piette, J., Yaniv, M., Tang, W.J. and Folk, W.R. (1988) Activation of the polyomavirus enhancer by a murine activator protein 1 (AP 1) homolog and two contiguous proteins. Proc. Natl. Acad. Sci. USA 85, 5839-5843.
15. [15] Monder, C. and White, P.C. (1993) 11 beta-hydroxysteroid dehydrogenase. Vitam. Hor. 47, 187-271.
16. [16] Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K. and White, P.C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat. Genet. 10, 394-399.
17. [17] Mutero, A., Camp, S. and Taylor, P. (1995) Promoter elements of the mouse acetylcholinesterase gene. J. Biol. Chem. 270, 1866-1872.
18. [18] Rusvai, E. and Naray-Fejes-Toth, A. (1993) A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 268, 10717-10720.
19. [19] Stewart, P.M., Rogerson, F.M. and Mason, J.I. (1995) Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 80, 885-890.
20. [20] Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. and White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J. Biol. Chem. 266, 16653-16658.
21. [21] Williams, T. and Tjian, R. (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP2. Genes Dev. 5, 670-682.